BIOREGENX, INC. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow
$70K
Free Cash Flow
$67K
Investing Cash Flow↑+100.0% +$191K
$0
Financing Cash Flow↑+52.5% +$24K
$71K
Capex
$3K
Stock-Based Comp↓-100.0% -$1M
$0
Debt Repaid
$3M
D&A↓-97.6% -$2M
$52K
SBC Allocated Expense↓-100.0% -$1M
$0